Curis Inc (CRIS): EPS (Basic)

Annual figures by period end, from SEC filings.

Stock splits: 1-for-20, first reflected in a filing dated 2023-11-02; 1-for-20, first reflected in a filing dated 2026-08-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$0.58
Year ended 2025-12-31
$0.502019-12-31: -$0.972020-12-31: -$0.612021-12-31: $0.502022-12-31: -$12.142023-12-31: -$8.962024-12-31: -$6.882025-12-31: -$0.58-$0.58
2019-12-31 EPS (Basic) (USD per share) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedEPS (Basic)Change YoYSource filing
2025-12-31-$0.58n/m2026-03-24, From 2025-01-01
2024-12-31-$6.88n/m2026-03-24, From 2024-01-01
2023-12-31-$8.96n/m2025-03-31, From 2023-01-01
2022-12-31-$12.14n/c2024-02-08, From 2022-01-01
2021-12-31$0.50n/c2023-03-13, From 2021-01-01
2020-12-31-$0.61n/m2022-02-24, From 2020-01-01
2019-12-31-$0.97n/a2022-02-24, From 2019-01-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Basic)Change YoY
Curis Inc (CRIS)2025-12-31-$0.58n/m
Taysha Gene Therapies, Inc. (TSHA)2025-12-31-$0.34n/m
Alpha Cognition Inc. (ACOG)2025-12-31-$1.17n/m
TScan Therapeutics, Inc. (TCRX)2025-12-31-$1.00n/m
Caribou Biosciences, Inc. (CRBU)2025-12-31-$1.59n/m
Fate Therapeutics Inc (FATE)2025-12-31-$1.15n/m
Lineage Cell Therapeutics, Inc. (LCTX)2025-12-31-$0.28n/m
Relay Therapeutics, Inc. (RLAY)2025-12-31-$1.61n/m
DBV Technologies S.A. (DBVT)2025-12-31-$1.05n/m

Compare CRIS, TSHA, ACOG, TCRX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗